COMPARATIVE TRIAL OF CEFTAZIDIME ALONE, CEFTAZIDIME + AMIKACIN AND CEFTAZIDIME + VANCOMYCIN AS EMPIRIC THERAPY OF FEBRILE CANCER-PATIENTS WITH INDUCED PROLONGED NEUTROPENIA

被引：13
|
作者：
MARIE, JP
PICO, J
LAPIERRE, V
MAULARD, C
PAPPO, M
CHICHE, D
ANDREMONT, A
LAGRANGE, P
HAYAT, M
ZITTOUN, R
机构：
来源：
MEDECINE ET MALADIES INFECTIEUSES | 1991年 / 21卷 / 07期
关键词：
FEVER; NEUTROPENIA; ANTIBIOTHERAPY;
D O I：
10.1016/S0399-077X(05)80140-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
The results of an empiric antibiotherapy in 223 febril episod in neutropenic patients showed that 1) the frequency of Gram positive strains in inaugural septicemia was 50%; 2) the use of vancomycin could not be delayed until the strain was isolated; 3) the use of 3 g/d of ceftazidime alone is feasible; 4) the frequence of Gram negative strains superinfections decreased when amikacin was added to ceftazidime; 5) the frequence of Gram positive strains superinfections decreased dramatically when vancomycin was added to ceftazidime.
引用
收藏
页码：386 / 388
页数：3
相关论文
共 50 条
  • [1] CEFTAZIDIME PLUS AMIKACIN VERSUS CEFTAZIDIME PLUS VANCOMYCIN AS EMPIRIC THERAPY IN FEBRILE NEUTROPENIC CHILDREN WITH CANCER
    VISCOLI, C
    MORONI, C
    BONI, L
    BRUZZI, P
    COMELLI, A
    DINI, G
    FABBRI, A
    SECONDO, V
    TERRAGNA, A
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1991, 13 (03): : 397 - 404
  • [2] A COMPARATIVE-STUDY OF CEFTRIAXONE PLUS AMIKACIN, CEFTAZIDIME PLUS AMIKACIN AND IMIPENEM CILASTATIN IN THE EMPIRIC THERAPY OF FEBRILE GRANULOCYTOPENIC CANCER-PATIENTS
    LIU, CY
    WANG, FD
    [J]. CHEMOTHERAPY, 1989, 35 : 16 - 22
  • [3] PHARMACOECONOMIC ANALYSIS OF EMPIRICAL THERAPY WITH CEFTAZIDIME ALONE OR COMBINATION ANTIBIOTICS FOR FEBRILE NEUTROPENIA IN CANCER-PATIENTS
    DRANITSARIS, G
    TRAN, TM
    MCGEER, A
    NARINE, L
    [J]. PHARMACOECONOMICS, 1995, 7 (01) : 49 - 62
  • [4] A COMPARISON OF IMIPENEM TO CEFTAZIDIME WITH OR WITHOUT AMIKACIN AS EMPIRIC THERAPY IN FEBRILE NEUTROPENIC PATIENTS
    ROLSTON, KVI
    BERKEY, P
    BODEY, GP
    ANAISSIE, EJ
    KHARDORI, NM
    JOSHI, JH
    KEATING, MJ
    HOLMES, FA
    CABANILLAS, FF
    ELTING, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (02) : 283 - 291
  • [5] CEFTAZIDIME PLUS TEICOPLANIN VERSUS CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN CANCER PATIENTS WITH GRANULOCYTOPENIA
    MEUNIER, F
    VANDERAUWERA, P
    AOUN, M
    BRON, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 : 49 - 53
  • [6] A RANDOMIZED TRIAL COMPARING CEFTAZIDIME ALONE WITH COMBINATION ANTIBIOTIC-THERAPY IN CANCER-PATIENTS WITH FEVER AND NEUTROPENIA
    PIZZO, PA
    HATHORN, JW
    HIEMENZ, J
    BROWNE, M
    COMMERS, J
    COTTON, D
    GRESS, J
    LONGO, D
    MARSHALL, D
    MCKNIGHT, J
    RUBIN, M
    SKELTON, J
    THALER, M
    WESLEY, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (09): : 552 - 558
  • [7] Efficacy of ceftazidime plus amikacin as an initial empirical therapy for adult patients with febrile neutropenia
    Alwan, A.
    Alshami, A.
    Alani, M.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S27 - S27
  • [8] Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients
    Nucci, M
    Biasoli, I
    Braggio, S
    Portugal, R
    Schaffel, R
    Maiolino, A
    Loureiro, MM
    Spector, N
    Pulcheri, W
    [J]. ONCOLOGY REPORTS, 1998, 5 (05) : 1205 - 1209
  • [9] CEFTAZIDIME WITH OR WITHOUT AMIKACIN FOR THE EMPIRIC TREATMENT OF LOCALIZED INFECTIONS IN FEBRILE, GRANULOCYTOPENIC PATIENTS
    NOVAKOVA, IRO
    DONNELLY, JP
    DEPAUW, BE
    [J]. ANNALS OF HEMATOLOGY, 1991, 63 (04) : 195 - 200
  • [10] A randomized clinical trial of ceftazidime and amikacin versus ceftriaxone and amikacin in febrile patients with hematological neoplasia and severe neutropenia
    Rossini, F
    Pioltelli, P
    Bolis, S
    Casaroli, I
    Lanzi, E
    Borin, L
    Maffe, P
    Tripputi, P
    Pogliani, EM
    Corneo, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1006 - 1006
12345